Ophthalmology Times E-News :
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Unsubscribe from this list.
Ophthalmology Times E-News
Modern Medicine Network
TOP SEARCHES: Retina Roundtable // CME // Practice Management
In this issue
Haiti relief efforts
Alcon buys Sirion assets
Ointment shipments begin
Wilmer collaboration
Reichert restructuring
Top advances of decade
GRF Catalyst Award
Key Topic Updates

OT360 BLOG
New IOL technology for the next decade

Contact Us
Click here to contact an Ophthalmology Times editor.

Click here to contact an Ophthalmology Times sales representative.

Click here to learn about direct mail, reprints, and classifieds in Ophthalmology Times.

February 4, 2010
Ophthalmology part of Haiti relief
Ophthalmologists, ophthalmic organizations, and companies operating in the ophthalmology arena are contributing to efforts to assist Haiti respond to and recover from the earthquake that occurred in January. More...
Alcon buys Sirion drug assets
Alcon Laboratories is purchasing rights in the United States for two FDA-approved topical eye-care products, difluprednate ophthalmic emulsion 0.05% (Durezol) and ganciclovir ophthalmic gel 0.15% (Zirgan), from Sirion Therapeutics Inc. More...
Fera shipping erythromycin, bacitracin ointments
Fera Pharmaceuticals is now shipping erythromycin and bacitracin ophthalmic ointments. More...
Wilmer Eye affiliates with Saudi Arabian eye hospital
The Wilmer Eye Institute, Johns Hopkins University School of Medicine, has established a collaboration with the King Khaled Eye Specialist Hospital in Riyadh, Saudi Arabia. More...
Reichert restructures marketing function
Reichert Inc. has restructured its marketing function in an effort “to meet the growing demands of the company’s vast product portfolio and improve performance through better focus and accountability,” according to Jerry C. Cirino, chairman and chief executive officer. More...
Anti-VEGF for AMD a top advancement
Anti-vascular endothelial growth factor (VEGF) treatments for neovascular age-related macular degeneration represent the most significant advancement in ophthalmology over the past decade, according to 52% of respondents to an online survey of members of the American Academy of Ophthalmology conducted in December. More...
Scientists honored at GRF benefit
Jeffrey B. Kindler, chief executive officer and chairman of the board of Pfizer Inc., received the Glaucoma Research Foundation Catalyst Award. More...
Key Topic Updates
Ophthalmic News
UV-blocking contact lens may protect eye from damage
Imaging finds problems with visual function in Alzheimer’s
Incidence of adverse events in contact lens wear studied
Pediatrics
Trial evaluates treatments for aphakia in infants
Bifocals appear to slow myopic progression in children
Rates of eye conditions differ among minority preschoolers
Retina
High caloric intake linked to diabetic retinopathy
Lifestyle linked to age-related macular degeneration
Melanoma-associated retinopathy biomarkers found
Career Opportunities

Retina and Ocular Plastic Physicians (NY)

Oculoplastic Fellowship (FL)

Fellowship Grant (Canada)
Medical Ophthalmologist, Glaucoma, Cornea, Oculoplastic Specialist (Canada)
Pediatric Ophthalmologist (MN)
Retina Specialist (Guam
Comprehensive Ophthalmology Opportunity (VT)
 

You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.